Humana and Mark Cuban's Cost Plus Drugs to Partner on Lowering Prescription Drug Prices
In a significant move, Humana, one of the nation's largest health insurers for older adults, is exploring a partnership with billionaire entrepreneur Mark Cuban's Cost Plus Drugs to lower prescription drug prices. The potential collaboration was announced at the annual Forbes Healthcare Summit, where both parties discussed ways to improve patient experience at pharmacies.
According to sources close to both companies, the initial focus will be on direct-to-employer programs that bypass traditional pharmacy benefit management (PBM) companies. Mark Cuban's Cost Plus Drugs is looking to capitalize on this trend, citing partnerships with CenterWell healthcare services business as a key strategy.
"We're working on these types of programs with CenterWell and the manufacturers," Cuban said. The partnership could be a boon for Cost Plus Drugs, given that Humana has over 8 million health plan enrollees, including more than 5 million in Medicare Advantage plans.
The deal is still in its early stages, but both parties are committed to streamlining the pharmacy experience and reducing unnecessary costs. Humana's CenterWell pharmacy business aims to "basically streamline how [medications] get from the plant to the consumer," Rechtin said. By contracting directly with manufacturers and eliminating intermediaries, consumers can see the face value of prescription drug prices.
"Their seeing the actual price of the drug which is much less than what you would typically see in the normal system," Rechtin added. "It allows us to basically give access at a lower cost and that's what we're doing with the direct-to-consumer model."
This partnership is the latest effort by Humana to innovate and grow its pharmacy business, following recent expansions into telehealth services and specialty pharmacies. By working together with Cost Plus Drugs, Humana aims to improve patient outcomes while reducing costs for employers and patients alike.
In a significant move, Humana, one of the nation's largest health insurers for older adults, is exploring a partnership with billionaire entrepreneur Mark Cuban's Cost Plus Drugs to lower prescription drug prices. The potential collaboration was announced at the annual Forbes Healthcare Summit, where both parties discussed ways to improve patient experience at pharmacies.
According to sources close to both companies, the initial focus will be on direct-to-employer programs that bypass traditional pharmacy benefit management (PBM) companies. Mark Cuban's Cost Plus Drugs is looking to capitalize on this trend, citing partnerships with CenterWell healthcare services business as a key strategy.
"We're working on these types of programs with CenterWell and the manufacturers," Cuban said. The partnership could be a boon for Cost Plus Drugs, given that Humana has over 8 million health plan enrollees, including more than 5 million in Medicare Advantage plans.
The deal is still in its early stages, but both parties are committed to streamlining the pharmacy experience and reducing unnecessary costs. Humana's CenterWell pharmacy business aims to "basically streamline how [medications] get from the plant to the consumer," Rechtin said. By contracting directly with manufacturers and eliminating intermediaries, consumers can see the face value of prescription drug prices.
"Their seeing the actual price of the drug which is much less than what you would typically see in the normal system," Rechtin added. "It allows us to basically give access at a lower cost and that's what we're doing with the direct-to-consumer model."
This partnership is the latest effort by Humana to innovate and grow its pharmacy business, following recent expansions into telehealth services and specialty pharmacies. By working together with Cost Plus Drugs, Humana aims to improve patient outcomes while reducing costs for employers and patients alike.